Subsidy Information and Financing Scheme MAFEnzalutamide Capsule 40 mg 1) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with h... See all × MAFEnzalutamide Capsule 40 mg 1) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC). 2) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with metastatic hormone-sensitive prostate cancer (mHSPC). 3) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with metastatic castration-resistant prostate cancer (mCRPC). MSHLEnzalutamide Capsule 40 mg 1) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with h... See all × MSHLEnzalutamide Capsule 40 mg 1) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC). 2) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with metastatic castration-resistant prostate cancer (mCRPC). 3) Enzalutamide in combination with androgen deprivation therapy (ADT) for treating patients with metastatic hormone-sensitive prostate cancer (mHSPC).
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Capsule 40 mg Changi General Hospital Khoo Teck Puat Hospital National Cancer Centre Ng Teng Fong General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus